MSC - Page 14

October 25, 2024

Exploring the Therapeutic Potential of Stem Cell-Derived Exosomes in Respiratory Diseases: A Pathway for Pulmonary Delivery

Exosomes, Regenerative Medicine, Stem Cell Research

Respiratory diseases are a major global health concern, responsible for millions of deaths each year. Conditions like chronic obstructive pulmonary disease (COPD), acute respiratory distress syndrome (ARDS), pulmonary fibrosis, and pneumonia claim many lives annually, and despite advancements in medical research, there is still no cure for many of these diseases. Current treatments typically focus…

August 27, 2024

Assessing the Safety of Intrathecal Mesenchymal Regenerative Medicine for Neurological Disorders: Insights from a Comprehensive Systematic Review and Meta-Analysis

Mesenchymal Stem Cells, Neurodegenerative Diseases, Stem Cell Research

Intrathecal cell delivery has emerged as a promising approach for improving the quality of life for patients with neurological conditions, thanks to previous studies showing its safety and potential benefits. As part of this review, Mesa Bedoya et al. summarize the findings of a systematic review and meta-analysis aimed at evaluating the safety of intrathecally…

August 21, 2024

Regenerative Medicine for Orthopedic Injuries: A Game Changer

Degenerative Disc Disease, Orthopedic Injuries, Osteoarthritis, Sports Injury Treatment

In recent years, the field of regenerative medicine has made remarkable strides, with regenerative medicine emerging as a revolutionary approach to treating various conditions. Among the most promising applications of regenerative medicine is its use in orthopedic injuries, which include conditions such as sports injuries, osteoarthritis, and stem cell therapy for degenerative disc disease. This…

August 15, 2024

Exploring the Efficacy and Safety of Mesenchymal Regenerative Medicine for Liver Cirrhosis

Mesenchymal Stem Cells, Stem Cell Research

Liver cirrhosis (LC) is a severe global health problem, contributing to an estimated two million deaths annually. LC results from chronic liver diseases such as hepatitis B and C, alcohol consumption, non-alcoholic fatty liver disease, and autoimmune liver disease. When these diseases progress unchecked, they lead to liver cirrhosis, characterized by inflammation and fibrosis. Most…

August 3, 2024

Phase II Trial Shows Promise of Repeated Stem Cell Injections for ALS Treatment

ALS, Mesenchymal Stem Cells, Stem Cell Research

Amyotrophic Lateral Sclerosis (ALS) is a degenerative disease that affects motor neurons in the brain and spinal cord, leading to muscle paralysis and death, typically within 3-5 years of onset. Despite two FDA-approved therapies, Riluzole, and Edravarone, which offer limited benefits, there remains no cure for ALS. Considering this, researchers have turned to Mesenchymal stem…

July 14, 2024

How Regenerative Medicine Has Revolutionized Neurodegenerative Disease Management

Health Awareness

Neurodegenerative diseases, which include conditions like amyotrophic lateral sclerosis (ALS), motor neuron disease, stem cell therapy for Parkinson disease’s disease, and stem cell therapy for multiple sclerosis (MS), are characterized by the progressive loss of structure and function of neurons. These conditions are currently considered incurable and utilize treatments focusing primarily on managing symptoms rather…

April 4, 2024

Utilizing Mesenchymal Stem Cells as an Innovative Therapeutic Strategy for Diabetes and Pancreatic Disorders

Diabetes, Mesenchymal Stem Cells, Regenerative Medicine, Stem Cell Research

According to the World Health Organization, an estimated 422 million people worldwide have diabetes. Numerous studies have demonstrated that people with diabetes are at an increased risk of developing both acute and chronic pancreatitis, which increases the risk of developing pancreatic cancer. Considering the lack of effective therapeutic options for pancreatitis and the limited treatment…

March 28, 2024

Reviewing The Effectiveness of Stem Cell Therapies in Managing Neuropathic Pain

Mesenchymal Stem Cells, Neuropathy, Stem Cell Research

The International Association for the Study of Pain defines neuropathic pain as “pain arising as a direct consequence of a lesion or disease affecting the somatosensory system”. While general neuropathy is diverse by nature, neuropathic lesions generally fall into four categories: focal or multifocal lesions of the peripheral system, general lesions of the peripheral nervous…

March 21, 2024

Regenerative Medicine Options for Neuropathy Pain Management

Mesenchymal Stem Cells, Neuropathy, Stem Cell Research

Neuropathic pain is pain caused as part of a dysfunction in the nervous system, including the peripheral nerves, brain, and spinal cord. Often characterized by spontaneous pain occurring for no specific reason, neuropathic pain can range from mild to severe and is currently estimated to affect 150 million people in the United States. The risk…

March 14, 2024

Mesenchymal Stem Cells for Managing Spinal Cord Injuries

Mesenchymal Stem Cells, Spinal Cord Injury, Stem Cell Research

Nerve damage resulting from stem cell therapy for spinal cord injury (SCI) often leads to temporary or permanent loss of function and contributes to poor quality of life. Most common among males below 30 years of age, SCI recovery has been limited specifically as a result of the low growth capacity of neurons and a…

Do you have questions?

We have answers. Speak with a Stemedix Care Coordinator today with no obligation. Give us a call!

800-531-0831